Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Contemporary treatment patterns and outcomes of salivary gland carcinoma: a National Cancer Database review.

Ferrell JK, Mace JC, Clayburgh D.

Eur Arch Otorhinolaryngol. 2019 Jan 16. doi: 10.1007/s00405-019-05282-2. [Epub ahead of print]

PMID:
30649610
2.

Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.

Amini A, Waxweiler TV, Brower JV, Jones BL, McDermott JD, Raben D, Ghosh D, Bowles DW, Karam SD.

JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1100-1110. doi: 10.1001/jamaoto.2016.2168.

PMID:
27541166
3.

Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.

Baddour HM Jr, Fedewa SA, Chen AY.

JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):67-73. doi: 10.1001/jamaoto.2015.2805.

PMID:
26632951
4.

A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.

Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, Kim S.

JAMA Otolaryngol Head Neck Surg. 2016 May 1;142(5):489-95. doi: 10.1001/jamaoto.2015.3930.

5.

Survival in oral cavity minor salivary gland carcinoma.

Kakarala K, Bhattacharyya N.

Otolaryngol Head Neck Surg. 2010 Jul;143(1):122-6. doi: 10.1016/j.otohns.2010.02.033.

PMID:
20620630
6.

Postoperative irradiation of minor salivary gland malignancies of the head and neck.

Le QT, Birdwell S, Terris DJ, Gabalski EC, Varghese A, Fee We Jr, Goffinet DR.

Radiother Oncol. 1999 Aug;52(2):165-71.

PMID:
10577702
7.

Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma.

Lee A, Givi B, Osborn VW, Schwartz D, Schreiber D.

Laryngoscope. 2017 Sep;127(9):2057-2062. doi: 10.1002/lary.26516. Epub 2017 Feb 14.

PMID:
28194862
8.

Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.

Boukheris H, Curtis RE, Land CE, Dores GM.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2899-906. doi: 10.1158/1055-9965.EPI-09-0638. Epub 2009 Oct 27.

9.

Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.

Schwarz S, Ettl T, Kleinsasser N, Hartmann A, Reichert TE, Driemel O.

Oral Oncol. 2008 Jun;44(6):563-70. Epub 2007 Oct 23.

PMID:
17936671
11.

Epidemiology, Prognostic Factors, and Treatment of Malignant Submandibular Gland Tumors: A Population-Based Cohort Analysis.

Lee RJ, Tan AP, Tong EL, Satyadev N, Christensen RE.

JAMA Otolaryngol Head Neck Surg. 2015 Oct;141(10):905-12.

PMID:
26378411
12.

Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.

Maruya S, Shirasaki T, Nagaki T, Kakehata S, Kurotaki H, Mizukami H, Shinkawa H.

BMC Cancer. 2009 Feb 27;9:72. doi: 10.1186/1471-2407-9-72.

13.

Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.

Schoenfeld JD, Sher DJ, Norris CM Jr, Haddad RI, Posner MR, Balboni TA, Tishler RB.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):308-14. doi: 10.1016/j.ijrobp.2010.09.042. Epub 2010 Nov 13.

PMID:
21075557
14.

Basal cell adenocarcinoma of the major salivary glands: A population-level study of 509 cases.

Zhan KY, Lentsch EJ.

Laryngoscope. 2016 May;126(5):1086-90. doi: 10.1002/lary.25713. Epub 2015 Oct 9.

PMID:
26451535
15.

Adjuvant radiation for salivary gland malignancies is associated with improved survival: A National Cancer Database analysis.

Bakst RL, Su W, Ozbek U, Knoll MA, Miles BA, Gupta V, Rhome R.

Adv Radiat Oncol. 2017 Apr 6;2(2):159-166. doi: 10.1016/j.adro.2017.03.008. eCollection 2017 Apr-Jun.

16.

Histologic grading and prognostic biomarkers in salivary gland carcinomas.

Seethala RR.

Adv Anat Pathol. 2011 Jan;18(1):29-45. doi: 10.1097/PAP.0b013e318202645a. Review.

PMID:
21169736
17.

Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases.

Scherl C, Kato MG, Erkul E, Graboyes EM, Nguyen SA, Chi AC, Morgan PF, Day TA.

Oral Oncol. 2018 Jul;82:53-60. doi: 10.1016/j.oraloncology.2018.05.002. Epub 2018 May 15.

PMID:
29909902
18.

Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA).

Bjørndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA, Homøe P, Sørensen CH, Andersen E, Bundgaard T, Primdahl H, Lambertsen K, Andersen LJ, Godballe C.

Oral Oncol. 2011 Jul;47(7):677-82. doi: 10.1016/j.oraloncology.2011.04.020. Epub 2011 May 25.

PMID:
21612974
19.

Salivary gland-like breast carcinomas: An infrequent disease.

Sherwell-Cabello S, Maffuz-Aziz A, Ríos-Luna NP, Bautista-Piña V, Rodríguez-Cuevas S.

Pathol Res Pract. 2016 Nov;212(11):1034-1038. doi: 10.1016/j.prp.2016.09.001. Epub 2016 Sep 13.

PMID:
27667558
20.

Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.

Reyes C, Jorda M, Gomez-Fernández C.

Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):283-6. doi: 10.1097/PAI.0b013e31826a277e. Review.

PMID:
22935826

Supplemental Content

Support Center